The production of a macrophage migration enhancement factor (MEF) has been achieved as a consequence of administering a desensitizing dose of purified protein derivative (PPD) to Mycobacterium bovis BCGsensitized rabbits. The migration-enhancing effect was first demonstrated when alveolar macrophages (AM) harvested from desensitized rabbits exhibited marked migration stimulation; whereas maximum migration enhancement was observed 8 days after the administration of PPD, migration enhancement of the AM from these rabbits persisted for up to 12 days. Sera from BCG-sensitized, PPD-desensitized animals exhibited a peak of MEF activity 4 days after desensitization. Maximal MEF activity was demonstrated in culture supernatants of nonadherent spleen cells harvested 8 days after the intravenous desensitizing dose of PPD was given. Control spleen cell culture supernatants did not produce detectable MEF. The route of desensitization with PPD was critical. When PPD was administrated intratracheally, MEF activity was not induced. The intravenous administration of BCG after PPD desensitization reversed migration enhancement to strong migration inhibition. Ammonium sulfate fractionation indicated that two fractions contained MEF activity. MEF activity was retained by dialysis membranes with a 15,000-molecular-weight cutoff but passed through dialysis membranes with a 25,000-molecular-weight cutoff. The mixture of migration inhibition factor with MEFcontaining supernatants resulted in the mutual cancellation of both activities. These observations suggest that MEF may be a modulator of macrophage effector responses mediated by migration inhibition factor.
The production of a macrophage migration enhancement factor (MEF) has been achieved as a consequence of administering a desensitizing dose of purified protein derivative (PPD) to Mycobacterium bovis BCGsensitized rabbits. The migration-enhancing effect was first demonstrated when alveolar macrophages (AM) harvested from desensitized rabbits exhibited marked migration stimulation; whereas maximum migration enhancement was observed 8 days after the administration of PPD, migration enhancement of the AM from these rabbits persisted for up to 12 days. Sera from BCG-sensitized, PPD-desensitized animals exhibited a peak of MEF activity 4 days after desensitization. Maximal MEF activity was demonstrated in culture supernatants of nonadherent spleen cells harvested 8 days after the intravenous desensitizing dose of PPD was given. Control spleen cell culture supernatants did not produce detectable MEF. The route of desensitization with PPD was critical. When PPD was administrated intratracheally, MEF activity was not induced. The intravenous administration of BCG after PPD desensitization reversed migration enhancement to strong migration inhibition. Ammonium sulfate fractionation indicated that two fractions contained MEF activity. MEF activity was retained by dialysis membranes with a 15,000-molecular-weight cutoff but passed through dialysis membranes with a 25,000-molecular-weight cutoff. The mixture of migration inhibition factor with MEFcontaining supernatants resulted in the mutual cancellation of both activities. These observations suggest that MEF may be a modulator of macrophage effector responses mediated by migration inhibition factor.
Assays for migration inhibition factor (MIF) have been plagued in many systems by wide variations in the degree of inhibition. It is of special interest that several investigators have observed stimulation of migration in some MIF assays. For example, migration stimulation has been observed when fetal bovine serum of lymph node supernatants were added to the migration assay system (1, 2). Weisbart et al. (16) were the first investigators to propose that the migration enhancement factor they studied was a lymphokine.
Studies on the interactions of MIF and migration enhancement factor(s) (MEF) are of special importance. Weisbart et al. (16) reported that their MEF cancelled the effects of MIF. In addition, Fox et al. (3) reported that migration stimulation factor and MIF neutralized each other in mixing experiments.
We have repeatedly noted that, when Mycobacterium bovis BCG-immunized rabbits are challenged intravenously (i.v.) or intratracheally (i.t.) with heat-killed BCG, they develop an extensive pulmonary granulomatous response after challenge (4, (8) (9) (10) (11) . In this case, the alveolar macrophages (AM) invariably exhibit migration inhibition when harvested and tested in the capillary tube migration test (no antigen added). We have referred to this phenomenon as autoinhibition (9) . In this case, the state of migration inhibition in vivo may be the result of MIF production by immune lymphocytes triggered by the antigens of BCG administered i.v. or i.t.
In contrast, when 1 mg of PPD is injected i.v. in a BCG-immunized rabbit, the AM harvested 8 days after injection exhibit marked enhancement of migration. We have observed also that AM from neonatal rabbits are in a state of migration enhancement compared with adult rabbit AM (14) . Enhanced AM migration was highest in 42-to 46-day-old animals but declined rapidly thereafter to normal adult levels. In addition, we have found that, when spleen cells from 42-day-old rabbits are cultured for 4 days, they spontaneously produce MEF. Sera from these young animals also stimulate the migration of adult AM. This communication will describe the induction, the cell source, and the partial characterization of an MEF that was induced by purified protein derivative (PPD) desensitization of adult rabbits.
MATERIALS AND METHODS
Animals. New Zealand White rabbits of either sex, weighing between 2 and 3 kg, were used in these experiments. They were sacrificed with a lethal dose (60 mg/kg) of pentobarbital (Barber Veterinary Supply, Fayetteville, N.C.).
BCG preparation. A BCG strain of M. bovis was grown on Proskauer-Beck broth. When the bacterial growth covered the entire surface of the medium, the cultures were autoclaved. The organisms were then harvested by filtration, washed three times with distilled water, suspended in a small volume of distilled water, lyophilized, and stored at -20°C. For use, lyophilized BCG was ground with a sterile mortar and pestle with mineral oil or saline. PPD of Mycobacterium tuberculosis was obtained from Connaught Laboratories, Willowdale, Ontario, Canada.
Immunization procedures. Rabbits were sensitized subcutaneously (s.c.) by injecting 200 ,ug of BCG in 0.2 ml of light mineral oil. The dose was divided into two sites, one at the base of each ear. After 21 days, the animals were skin tested by injecting 25 (Fig. 1, fourth bar) . In contrast, AM from BCG-sensitized, PPD-desensitized animals showed a large enhancement in migration (2 to 2.5 times) compared with control AM (Fig. 1, second bar) . It is of special interest that the stimulation produced by the PPD desensitization was reversed by a subsequent challenge with BCG ( Fig. 1, third bar) . Photographs of representative migrations are presented in Fig. 2 . Time course of enhanced migration of AM from BCGsensitized, PPD-desensitized rabbits. A series of experiments was carried out to determine the optimal interval after PPD was given which produced maximal migration stimulation of AM. Rabbits were sensitized s.c. with BCG and given 1 mg of PPD i.v. 3 weeks later. Alveolar cells were harvested 2, 4, 8, and 12 days after administration of PPD. Maximal migration enhancement occurred 8 days after PPD challenge (Fig.  3) . It can be noted that sensitized controls (Fig. 3, sixth bar) that did not receive PPD showed control migration patterns. In addition, AM from nonsensitized animals that received PPD also exhibited normal migration patterns (Fig. 3 , seventh bar).
Demonstration of an MEF in the sera of BCG-sensitized, PPD-desensitized rabbits. A time course experiment was done to determine the interval after the administration of PPD which resulted in maximal MEF activity of the sera. Six animals were bled serially, and their sera were tested in the standard migration assay. The results summarized in Fig. 4 were obtained from one animal and are representative of the experiment. It is noteworthy that peak MEF activity occurred 4 days after PPD desensitization. It can be recognized that peak MEF activity in the sera preceded peak resident AM migration enhancement by about 4 days.
Effect of route of PPD administration on the migration enhancement of AM. Three weeks after BCG sensitization, rabbits were given 1 mg of PPD either i.t. or i.v. Alveolar cells were harvested either 2 or 4 days after administration of PPD. The results reveal that an i.t. injection of PPD resulted in migration inhibition, whereas an i.v. injection of PPD resulted in marked stimulation of migration. (Fig. 5) .
Studies on spleen cells as a possible source of MEF. Since PPD desensitization by the i.v. route was required to induce MEF, spleen cells were implicated as a possible source of MEF. Accordingly, spleen cells were harvested from BCGsensitized rabbits 4 days after i.v. administration of PPD. The spleen cell cultures were incubated for 4 days, and the supernatants were harvested and tested for MEF activity with adult normal AM.
The results indicate that spleen cell supernatants from BCG-sensitized, PPD-desensitized rabbits markedly stimulated the migration of control AM (Fig. 6) . It is important to note that comparable spleen cell culture supernatants prepared from control rabbits had no detectable MEF activity. In particular, spleen cell supernatants from nonsensitized rabbits that received PPD were inactive.
Lavage Ammonium sulfate fractionation of MEF from spleen cell culture supernatants. Spleen cell supernatants known to contain MEF activity were subjected to ammonium sulfate precipitation. The collected fractions were dialyzed to remove the ammonium sulfate. The dialyzed fractions were reconstituted in RPMI 1640 and tested in the migration assay. The data revealed MEF activity in two fractions (50 to 60% and 70 to 85%). Most of the MEF activity resided in the 50 to 60% fraction.
Estimation of molecular weight of MEF by using dialysis membranes with various molecular weight cutoffs. Spleen cell supernatants known to contain MEF activity were dialyzed against distilled water by using membranes with molecular weight cutoffs of 6,000, 10,000, 15,000, 25,000, and 50,000. MEF activity was retained by membranes with a molecular weight cutoff of 15,000 but not by membranes with a cutoff of 25,000. This indicates that MEF has a molecular weight between 15,000 and 25,000. Because dialysis is largely dependent on molecular shape and size, the molecular weight cutoff can only be a rough approximation. DISCUSSION The data obtained in this study clearly establish that the desensitization protocol with PPD administered i.v. leads to the generation of a macrophage MEF. To our knowledge, this is the first demonstration of MEF induction as result of an in vivo immunologic protocol. It is of particular importance to note that MEF appeared in the sera of desensitized rabbits a few days before the peak migration stimulation exhibited by the resident AM. This would suggest that spleen cells are mobilized or induced or both to make MEF after the i.v. dose of PPD. Accordingly, MEF is most likely transported to the AM in the lung by way of the circulation.
The requirement that the desensitizing dose of PPD must be given i.v. strongly supports the idea that MEF is made by cells in the spleen. For example, when PPD was administered i.t., no macrophage migration enhancement was expressed by resident AM. In some instances, migration inhibition was noted after the administration of PPD by the i.t. route. These data support the idea that cells in the lung do not make MEF under the conditions of our experiments.
It is of special interest that a suspension of BCG given i.v. to BCG-sensitized rabbits produced migration inhibition instead of migration enhancement. It appears that the induction of MEF requires a soluble form of the antigen. In this regard, we have demonstrated that soluble PPD does not elicit granulomas, whereas PPD made insoluble by crosslinking with glutaraldehyde elicits typical tubercle-type granulomas (7). The mechanisms involved which require soluble antigens to produce MEF are not known.
The spleen cells responsible for the synthesis of MEF appear to be nonadherent lymphoid cells. The difficulties in determining whether the cells were PNA+ or PNA-could be due to the large numbers of PNA-cells present in the adult spleen. Nevertheless, the cells responsible for MEF production could be similar to the nonadherent PNA-agglutinable neonatal spleen cells which synthesize MEF spontaneously in culture (14) .
The molecular weight of MEF remains uncertain, based on the data obtained in our study. The results of dialysis membrane cutoff experiments suggest a molecular weight of between 15,000 and 25,000. The ammonium sulfate fractionation studies suggest a higher molecular weight. Experiments in progress are concerned with the resolution of this ambiguity.
The major point of interest in this work stems from the observation that a desensitizing dose of PPD can induce production of a macrophage MEF which appears to be an antagonist of MIF. Our studies, as well as others, indicate that the effects of MIF and MEF, which appear to be modulators of macrophage migration, cancel each other when they are mixed together. Additionally, the rise in MEF activity with increasing dilution of spleen cell supernatants suggests the presence of an antagonist in cultured spleen cell supernatants which could possibly be MIF. The observation that a BCG challenge superimposed on PPD desensitization can reverse migration enhancement supports the idea that modulation of a cell-mediated immune response can occur in vivo. In this particular case it was noted that the marked migration enhancement that was induced by PPD desensitization was reversed to an intenge migration inhibition by the BCG challenge dose.
The possible role of MEF in mediating anergy is still uncertain. Desensitization produces many events, and it is unlikely that anergy results only from the production of MEF. For example, desensitization with PPD by the i.v. route seems to deplete the circulation of immune T cells. Furthermore, there is some evidence that desensitization will drive circulating T cells into the tissue. Accordingly, dermal anergy could be the result of depletion of circulating immune T cells. Nevertheless, the possible role of MEF in preventing or attenuating macrophage participation in a cell-mediated immune response warrants further study.
It is of special interest that the enhanced migration of resident AM in desensitized rabbits persists for about the same time as anergy is sustained. For example, stimulated migration of AM from BCG-sensitized, PPD-desensitized animals persisted for up to 12 days after administration of PPD. It was also noted that dermal responsiveness returned shortly after that interval. The persistence of the enhanced migration of AM in desensitized rabbits even after MEF was not detectable in the serum was unexpected; this suggests that the migration stimulatory effects persist because MEF is bound but not rapidly metabolized by AM or that the AM Can retain enhanced migration even when the availability of MEF is curtailed. Collectively, the data from our laboratory support the concept that MEF is a lymphokine that could be an important modulator of cell-mediated immune responses. In view of our observation that immature PNA+ lymphoid cells from the spleen of neonatal rabbits produce MEF spontaneously, we postulate that MEF could be a lymphokine made by nonspecific (natural) suppressor cells (13, 14) , which are prevalent in the neonatal spleen. This hypothesis is being investigated in experiments currently in progress.
